Sector Investors News and Insights

Sangamo Therapeutics is experiencing a 50% drop in premarket trading due to negative news from Pfizer.

Sangamo Therapeutics down 50% premarket on Pfizer blow…

Read More: https://www.proactiveinvestors.co.uk/companies/news/1063536/sangamo-therapeutics-down-50-premarket-on-pfizer-blow-1063536.html

More News

© 2025 ETF Sector

Scroll to Top

Subscribe to our Newsletter

Stay updated with the latests analysis and insights fromm etfsector.com

If you haven’t received your newsletter email, check your spam/junk folder and add us to your contacts to ensure delivery.